NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

心脏结构设备市场 - 成长,趋势,预测

Structural Heart Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品编码 921267
出版日期 内容资讯 英文 114 Pages
商品交期: 2-3个工作天内
价格
心脏结构设备市场 - 成长,趋势,预测 Structural Heart Devices Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日内容资讯: 英文 114 Pages
简介

主要结构的心脏病,有关联的适应症,以及心房中膈缺损症,主动脉阀狭窄症,末梢动静脉瘘等。作为剖腹手术的替代手段,微创设备的采用踏实增加,使心脏结构设备市场需求扩大。还有,医疗保健费的改善,从风险企业合作伙伴资金提供推动创新的医疗设备企业,小规模商务的创新调查对创新计划的踏实参加,也提高心脏血管设备的需求。

本报告提供心脏结构设备的世界市场调查,市场概要,各类型、治疗、地区的市场趋势,市场规模的变化与预测,市场促进、阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 调查成果
  • 调查的前提条件
  • 调查范围

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 市场概要
  • 成长要素
  • 阻碍因素
  • 波特的五力分析
    • 新加入厂商的威胁
    • 消费者谈判力
    • 供应商谈判力
    • 替代产品的威胁
    • 产业内的竞争

第5章 市场区隔

  • 各产品
    • 心脏瓣膜设备
    • 封堵器、输送系统
    • 环状成形术环
    • 其他
  • 各治疗
    • 替换
    • 修复式
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第6章 竞争情形

  • 企业简介
    • Abbott Laboratories
    • Biomerics, LLC
    • Boston Scientific Corporation
    • Braile Biomedica
    • Comed BV
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • Lepu Medical
    • LivaNova PLC
    • Medtronic PLC

第7章 市场机会及未来趋势

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 67126

In the modern advances of medical sciences, many medical heart device companies and institutes are focusing upon several ways to replace or repair structural heart diseases such as congenital and age-related heart defects.

There is a significant growth over the decade in the type of complexities which are presented by the cardiovascular patients. To curb them, structural heart devices play a significant role in the treatment of chronic heart disorders. The initiatives and awareness programs by the government and private sector in collaboration with cardiac specialized hospitals also drive the adoption of such devices in the healthcare facilities.

Some of the major structural heart diseases having a significant burden across the world include atrial septal defects, aortic stenosis, peripheral arteriovenous fistula, along with related indications. As an alternative to open surgeries, there has been a steady increase in the adoption of minimally invasive devices which also drives the demand for structural heart devices market, over the forecast period.

Key Market Trends

Replacement Procedures is Expected to Contribute to Significant Revenue Over the Forecast Period

The transcatheter aortic valve replacement (TAVR) is one of the noticeable advances under the replacement procedures segment, TAVR has gained attention because of growing adoption of minimally invasive surgical procedures. Under sedative medications, the procedure lasts for a shorter period than open heart surgery and is highly useful for patients with severe aortic stenosis (AS). In many multispeciality healthcare facilities, the replacement therapies are considered to be safer, offer better effectiveness and are applicable to a greater range of patient population, as per the study published in the Annals of Cardiothoracic Surgery, 2017.

Furthermore, the better participation by the government authorities to push more on innovation and better distribution network across the cities are expected to drive and provide steady growth to replacement procedures, over the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America is the major contributing geography for the structural heart devices market. The presence of better awareness in the society regarding the heart indications and well-organized infrastructure in the cities of the United States ad Canada, along with the faster approval process of medical devices in the region, are a few of the important factors driving the growth of the studied market in this region.

The better healthcare expenditure, boost to innovative medical device companies through funding from venture partners, and steady participation of small business innovation research in the innovative projects drives the demand of cardiovascular devices and positively impacting the growth of structural heart devices.

Competitive Landscape

The market is moderatley fragmented with signicant contribution of several public and private private companies operating at the global level. Many companies are now exploring collabroation opportunities in many of medical tourism destinations across the emerging markets of the world. Some of the top players include Abbott Laboratories, Boston Scientific Coporation, Medtronic PLC, Lepu Medical, Edwards Life Sciences Corporation, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Technological Advancement in Medical Devices
    • 4.2.3 Growing Participation of Government and Private Sector
  • 4.3 Market Restraints
    • 4.3.1 Less Accessibility to New Technology in the Emerging Markets
    • 4.3.2 Irregular Reimbursement Scenario
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Heart Valve Devices
    • 5.1.2 Occluders & Delivery Systems
    • 5.1.3 Annuloplasty Rings
    • 5.1.4 Other Products
  • 5.2 By Procedure
    • 5.2.1 Replacement Procedures
    • 5.2.2 Repair Procedures
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 France
      • 5.3.2.2 Germany
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biomerics, LLC
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Braile Biomedica
    • 6.1.5 Comed B.V.
    • 6.1.6 Edwards Lifesciences Corporation
    • 6.1.7 JenaValve Technology, Inc.
    • 6.1.8 Lepu Medical
    • 6.1.9 LivaNova PLC
    • 6.1.10 Medtronic PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS